Cognitive deficits after recovery from thrombotic thrombocytopenic purpura
- 1 June 2009
- journal article
- Published by Wiley in Transfusion
- Vol. 49 (6), 1092-1101
- https://doi.org/10.1111/j.1537-2995.2009.02101.x
Abstract
BACKGROUND: Patients with apparent complete recovery from thrombotic thrombocytopenic purpura (TTP) often complain of problems with memory, concentration, and fatigue. STUDY DESIGN AND METHODS: Twenty-four patients who were enrolled in the Oklahoma TTP-HUS Registry for their initial episode of TTP, 1995-2006, and who had ADAMTS13 activity of less than 10 percent were evaluated for a broad range of cognitive functions 0.1 to 10.6 years (median, 4.0 years) after their most recent episode. At the time of their evaluation, they had normal physical and Mini-Mental State Examinations and no evidence of TTP. RESULTS: The patients, as a group, performed significantly worse on 4 of the 11 cognitive domains tested than standardized US data from neurologically normal individuals adjusted for age, sex, and education (p < 0.05). These four domains measured complex attention and concentration skills, information processing speed, rapid language generation, and rote memorization. Twenty-one (88%) patients performed below expectations on at least 1 of the 11 domains. No clear patterns were observed between cognitive test results and patients' characteristics or features of the preceding TTP, including age, occurrence of severe neurologic abnormalities, multiple episodes, and interval from an acute episode. CONCLUSION: Patients who have recovered from TTP may have persistent cognitive abnormalities. The abnormalities observed in these patients are characteristic of disorders associated with diffuse subcortical microvascular disease. Studies of larger patient groups will be required to confirm these preliminary observations and to determine patient characteristics that may contribute to persistent cognitive abnormalities.Keywords
This publication has 22 references indexed in Scilit:
- Long‐term deficits in health‐related quality of life after recovery from thrombotic thrombocytopenic purpuraTransfusion, 2008
- The Oklahoma Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome Registry: the Swiss connectionEuropean Journal of Haematology, 2008
- Support groups for patients who have recovered from thrombotic thrombocytopenic purpuraJournal of Clinical Apheresis, 2008
- A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpuraTransfusion Medicine, 2007
- An Evaluation of the Clinical Utility of the OPIE-3 as an Estimate of Premorbid WAIS-III FSIQThe Clinical Neuropsychologist, 2003
- A support group for patients who have recovered from thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome (TTP‐HUS): The six‐year experience of the Oklahoma TTP‐HUS Study GroupJournal of Clinical Apheresis, 2003
- Estimation of WAIS-III Intelligence from Combined Performance and Demographic Variables: Development of the OPIE-3The Clinical Neuropsychologist, 2002
- Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpuraBlood, 2002
- Neuropsychological sequelae of haemolytic uraemic syndromeArchives of Disease in Childhood, 1999
- THROMBOTIC THROMBOCYTOPENIC PURPURAMedicine, 1966